19-10180505-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001130823.3(DNMT1):​c.290A>G​(p.His97Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00824 in 1,614,168 control chromosomes in the GnomAD database, including 1,034 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H97Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 142 hom., cov: 31)
Exomes 𝑓: 0.0079 ( 892 hom. )

Consequence

DNMT1
NM_001130823.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0510

Publications

69 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013153255).
BP6
Variant 19-10180505-T-C is Benign according to our data. Variant chr19-10180505-T-C is described in ClinVar as Benign. ClinVar VariationId is 257539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNMT1NM_001130823.3 linkc.290A>G p.His97Arg missense_variant Exon 4 of 41 ENST00000359526.9 NP_001124295.1
DNMT1NM_001318730.2 linkc.290A>G p.His97Arg missense_variant Exon 4 of 40 NP_001305659.1
DNMT1NM_001379.4 linkc.290A>G p.His97Arg missense_variant Exon 4 of 40 NP_001370.1
DNMT1NM_001318731.2 linkc.-74A>G 5_prime_UTR_variant Exon 4 of 41 NP_001305660.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNMT1ENST00000359526.9 linkc.290A>G p.His97Arg missense_variant Exon 4 of 41 1 NM_001130823.3 ENSP00000352516.3

Frequencies

GnomAD3 genomes
AF:
0.0119
AC:
1818
AN:
152156
Hom.:
141
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00251
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0395
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.00766
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0245
AC:
6155
AN:
251494
AF XY:
0.0211
show subpopulations
Gnomad AFR exome
AF:
0.00283
Gnomad AMR exome
AF:
0.0567
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.211
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000237
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.00786
AC:
11484
AN:
1461894
Hom.:
892
Cov.:
31
AF XY:
0.00755
AC XY:
5490
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00179
AC:
60
AN:
33480
American (AMR)
AF:
0.0548
AC:
2450
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26136
East Asian (EAS)
AF:
0.189
AC:
7487
AN:
39700
South Asian (SAS)
AF:
0.00523
AC:
451
AN:
86258
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53420
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000161
AC:
179
AN:
1112012
Other (OTH)
AF:
0.0135
AC:
815
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
754
1508
2262
3016
3770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0120
AC:
1822
AN:
152274
Hom.:
142
Cov.:
31
AF XY:
0.0130
AC XY:
966
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00250
AC:
104
AN:
41568
American (AMR)
AF:
0.0397
AC:
607
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.198
AC:
1026
AN:
5170
South Asian (SAS)
AF:
0.00767
AC:
37
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68026
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
76
152
229
305
381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00726
Hom.:
242
Bravo
AF:
0.0160
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00318
AC:
14
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.0217
AC:
2637
Asia WGS
AF:
0.0780
AC:
272
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 30, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Sep 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Hereditary sensory neuropathy-deafness-dementia syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
12
DANN
Benign
0.82
DEOGEN2
Uncertain
0.42
T;.;T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.74
T;T;T
MetaRNN
Benign
0.0013
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
0.051
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.0
N;N;.
REVEL
Benign
0.021
Sift
Benign
0.88
T;T;.
Sift4G
Benign
0.72
T;T;T
Vest4
0.27
ClinPred
0.0067
T
GERP RS
2.1
PromoterAI
-0.0049
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.024
gMVP
0.16
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16999593; hg19: chr19-10291181; COSMIC: COSV61577559; COSMIC: COSV61577559; API